S&P 500
(0.46%) 5 270.61 points
Dow Jones
(0.37%) 39 703 points
Nasdaq
(0.45%) 16 586 points
Oil
(-1.61%) $76.76
Gas
(-0.34%) $2.34
Gold
(0.03%) $2 360.50
Silver
(0.79%) $28.93
Platinum
(1.01%) $1 055.10
USD/EUR
(-0.13%) $0.923
USD/NOK
(-0.16%) $10.78
USD/GBP
(-0.22%) $0.793
USD/RUB
(-0.40%) $90.96

Realtime updates for Coeptis Therapeutics, [COEP]

Exchange: OTC Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-20)

Expected move: +/- 0.00%

Last Updated15 May 2024 @ 09:55

2.07% $ 0.370

Live Chart Being Loaded With Signals

Commentary (15 May 2024 @ 09:55):

Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer...

Stats
Today's Volume 16 165.00
Average Volume 260 591
Market Cap 13.35M
EPS $0 ( 2024-03-28 )
Next earnings date ( $0 ) 2024-05-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.450
ATR14 $0.00300 (0.81%)
Insider Trading
Date Person Action Amount type
2024-01-10 Cogley Brian Buy 5 000 Common Stock
2024-01-10 Cogley Brian Sell 0 Common Stock
2024-01-12 Desilva Tara Buy 1 800 Common Stock
2024-01-12 Desilva Tara Buy 466 Common Stock
2024-01-05 Yerace Daniel Alexander Buy 10 850 Common Stock
INSIDER POWER
66.41
Last 46 transactions
Buy: 10 280 996 | Sell: 12 141 291

Coeptis Therapeutics, Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Coeptis Therapeutics, Financials

Annual 2023
Revenue: $0
Gross Profit: $-1.00M (0.00 %)
EPS: $-0.830
FY 2023
Revenue: $0
Gross Profit: $-1.00M (0.00 %)
EPS: $-0.830
FY 2022
Revenue: $0
Gross Profit: $-1.00M (0.00 %)
EPS: $-2.87
FY 2021
Revenue: $75 000.00
Gross Profit: $75 000.00 (100.00 %)
EPS: $-0.689

Financial Reports:

No articles found.

Coeptis Therapeutics, Options Data

Array
Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Coeptis Therapeutics,

Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators